Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model
Qifei Li(Guangxi Maternal and Child Health Hospital), Pankaj B. Agrawal(Post Graduate Institute of Medical Education and Research), Tracy Zhang(Boston Children's Hospital), Jasmine Lin(Boston Children's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Jocelyn Laporte(Centre National de la Recherche Scientifique), Xiaoli Liu(Qingdao Agricultural University), Jeffrey J. Widrick(University of Massachusetts Chan Medical School), Gu Li(Southwest Medical University), Shiyu Luo(Cincinnati Children's Hospital Medical Center)
Cited by 12
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710